Title of article
Bladder Tuberculosis after BCG Therapy
Author/Authors
Bouhabel, A Constantine Military Hospital - Departments of Nephrology, Urology, and Pathology, Algeria , Takoucht, F Constantine Military Hospital - Departments of Nephrology, Urology, and Pathology, Algeria , Bousbia, W Constantine Military Hospital - Departments of Nephrology, Urology, and Pathology, Algeria , Hamada, B Constantine Military Hospital - Departments of Nephrology, Urology, and Pathology, Algeria , Lemaiaci, N Constantine Military Hospital - Departments of Nephrology, Urology, and Pathology, Algeria
From page
80
To page
81
Abstract
The initial treatment of bladder cancer is transurethral resection (TUR), but this cancer recurs at an important rate, and has 14% chance of progression after TUR alone. Intravesical chemotherapy with Bacillus Calmette-Guerin (BCG) is effective against recurrence and progression of bladder cancer. However, this therapeutic expose to many local and systemic side-effects. We report a case of 63-year-old man who presented bladder tuberculosis after a BCG therapy, which required 6 months of antitubercular therapy.
Keywords
Bladder cancer , BCG therapy , Tuberculosis , Antitubercular
Journal title
Saudi Journal of Kidney Diseases and Transplantation
Journal title
Saudi Journal of Kidney Diseases and Transplantation
Record number
2674154
Link To Document